321 related articles for article (PubMed ID: 18049311)
1. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways.
de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C
J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention.
Balestrieri ML; Lu SJ; de Nigris F; Giovane A; Williams-Ignarro S; D'Armiento FP; Feng Q; Fiorito C; Testa G; Pastore L; Cacciatore F; Mancini FP; Servillo L; De Rosa G; Pagliarulo C; Rienzo M; Minucci PB; Farzati B; Salvatore F; Rengo F; Ignarro LJ; Giordano A; Baker A; Lanza R; Napoli C
Atherosclerosis; 2010 Apr; 209(2):403-14. PubMed ID: 19932479
[TBL] [Abstract][Full Text] [Related]
4. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.
Napoli C; Williams-Ignarro S; de Nigris F; de Rosa G; Lerman LO; Farzati B; Matarazzo A; Sica G; Botti C; Fiore A; Byrns RE; Sumi D; Sica V; Ignarro LJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17202-6. PubMed ID: 16286655
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats.
Imanishi T; Kobayashi K; Hano T; Nishio I
Hypertens Res; 2005 Sep; 28(9):763-72. PubMed ID: 16419650
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy.
Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C
J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
[TBL] [Abstract][Full Text] [Related]
10. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis.
Sumi M; Sata M; Miura S; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):813-8. PubMed ID: 17272742
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
12. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy.
You D; Waeckel L; Ebrahimian TG; Blanc-Brude O; Foubert P; Barateau V; Duriez M; Lericousse-Roussanne S; Vilar J; Dejana E; Tobelem G; Lévy BI; Silvestre JS
Circulation; 2006 Jul; 114(4):328-38. PubMed ID: 16847153
[TBL] [Abstract][Full Text] [Related]
13. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Ii M; Nishimura H; Iwakura A; Wecker A; Eaton E; Asahara T; Losordo DW
Circulation; 2005 Mar; 111(9):1114-20. PubMed ID: 15723985
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice.
Qi X; Okamoto Y; Murakawa T; Wang F; Oyama O; Ohkawa R; Yoshioka K; Du W; Sugimoto N; Yatomi Y; Takuwa N; Takuwa Y
Eur J Pharmacol; 2010 May; 634(1-3):121-31. PubMed ID: 20206620
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb.
Sica V; Williams-Ignarro S; de Nigris F; D'Armiento FP; Lerman LO; Balestrieri ML; Maione C; Palagiano A; Rossiello L; Ignarro LJ; Napoli C
Cell Cycle; 2006 Dec; 5(24):2903-8. PubMed ID: 17172874
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
Sasaki K; Heeschen C; Aicher A; Ziebart T; Honold J; Urbich C; Rossig L; Koehl U; Koyanagi M; Mohamed A; Brandes RP; Martin H; Zeiher AM; Dimmeler S
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14537-41. PubMed ID: 16983080
[TBL] [Abstract][Full Text] [Related]
19. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis.
Fernandes T; Nakamuta JS; Magalhães FC; Roque FR; Lavini-Ramos C; Schettert IT; Coelho V; Krieger JE; Oliveira EM
J Hypertens; 2012 Nov; 30(11):2133-43. PubMed ID: 23052048
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
